Log in to save to my catalogue

Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins usi...

Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins usi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8ae9588c1f8248e687d2d13c4fd88a8b

Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening

About this item

Full title

Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Future Journal of Pharmaceutical Sciences, 2020-06, Vol.6 (1), p.18-10, Article 18

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Leishmaniasis is a disease caused by protozoan forms called
Leishmania
which infect animals and humans. The drugs have been in use since half a century due to which there have been mutations in the microbe-facilitating drug resistance. So this provides a reason for searching for effective drugs for the disease. In the current wo...

Alternative Titles

Full title

Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8ae9588c1f8248e687d2d13c4fd88a8b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8ae9588c1f8248e687d2d13c4fd88a8b

Other Identifiers

ISSN

2314-7253,2314-7245

E-ISSN

2314-7253

DOI

10.1186/s43094-020-00038-w

How to access this item